Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Benicar Enteropathy Misdiagnosis May Have Caused Long-Term GI Injury May 21, 2014 Austin Kirk Add Your Comments Recent studies and data have found a strong link between side effects of Benicar and chronic diarrhea, which often resolves when the medication is no longer used. However, a growing number of lawsuits filed by former users allege that the lack of warnings provided by the drug maker caused these problems to be misdiagnosed for months or even years, resulting in long-term gastrointestinal injury. Benicar (olmesartan medoxomil) is a widely-used blood pressure drug that was first approved by the FDA in 2002. It is distributed by Daiichi Sankyo and Forest Laboratories in the U.S., and other versions of the medication are sold under the brand names Benicar HCT, Azor and Tribenzor. Although the drug has been on the market for more than 10 years, many consumers and doctors are just now learning about the link between Benicar and diarrhea problems known as sprue-like enteropathy. Learn More About Benicar Lawsuits Side Effects of Benicar May Cause Diarrhea, Villous Atrophy and Sprue-Like Enteropathy Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Benicar Lawsuits Side Effects of Benicar May Cause Diarrhea, Villous Atrophy and Sprue-Like Enteropathy Learn More SEE IF YOU QUALIFY FOR COMPENSATION Benicar and Sprue-Like Enteropathy Risk The first published study on the issue was released in July 2012, when researchers from the Mayo Clinic identified at least 22 patients from 17 different states treated for symptoms consistent with celiac disease while taking Benicar. However, the report indicated that once patients stopped using the medication, their symptoms usually resolved. Warnings about the risk of chronic diarrhea symptoms caused by Benicar were first issued in July 2013, when the FDA released a drug safety communication to inform consumers and the medical community about the risk of sprue-like enteropathy from Benicar. The federal drug regulators indicated that these problems may surface months or even years after an individuals starts using the medication. Sprue-like enteropathy is a medical condition associated with chronic diarrhea, nausea, vomiting, weight loss and other gastrointestinal problems. Although research has suggested that diarrhea symptoms often resolve when Benicar is no longer used, the problems can cause permanent damage to the intestines, known as villous atrophy. This involves the deterioration or decay of the villa in the intestinal tract, which may prevent the absorption of nutrients and reduce digestive capabilities. Left untreated, villous atrophy may result in dehydration, malnutrition, a weakened ability to fight off other illness and electrolyte problems. Misdiagnosis of Benicar Problems Because doctors and the medical community were unaware of the possibility that Benicar may be causing the symptoms, many individuals have been misdiagnosed as having celiac disease or unclassified sprue, resulting in continued use of the medication. Celiac disease is an autoimmune disorder that is only known to occur among individuals with a genetic predisposition. Although there is no known cure for the disease, adherence to a gluten fee diet often helps reduce the symptoms of pain or discomfort in the digestive tract, chronic constipation, diarrhea and fatigue. For users of Benicar misdiagnosed with celiac disease, they often report no response to changes in their diet and symptoms continue until they stop taking the medication. Many cases of problems associated with Benicar have been misdiagnosed in recent years as unclassified sprue, which is sometimes referred to as unclassified enteropathy. These terms are used to describe cases where the precise cause of the sprue-like condition can not be determined. Since the connection was discovered between Benicar and chronic diarrhea, the Celiac Disease Center has suggested that Benicar may have been responsible for 22% of all cases of previously unclassified sprue. In a report published earlier this year in the medical journal Case Reports in Gastrointestinal Medicine, researchers from the Conemaugh Memorial Medical Center highlighted how recognition of the link between Benicar and enteropathy may explain a good proportion of cases previously considered unclassified sprue. In 2012, it was reported that a diagnosis of unclassified sprue or unclassified enteropathy was made in 33% of patients with villous atrophy who tested negative for celiac disease. However, by 2013, after information was provided about the potential link between sprue and Benicar, the reported percentage was only 14% in the unclassified category, which researchers indicated would have increased to 30% if the Benicar enteropathy risk was still unknown. As more and more consumers learn that their severe and debilitating GI injuries may have been caused by the blood pressure mediation, a growing number of Benicar lawsuits are being filed against Daiichi Sankyo and Forest. All of the complaints involve similar claims that the drug makers knew or should have known about the risk, but failed to provide adequate warnings. Many of the plaintiffs allege that if they had been warned to seek medical attention if they developed diarrhea or other symptoms of sprue-like enteropathy, they may have avoided long-term gastrointestinal injury caused by the misdiagnosis of their condition. Tags: Benicar, Daiichi Sankyo, Forest Laboratories, Hypertension, Sprue, Villous Atrophy Image Credit: | More Benicar Lawsuit Stories Benicar Recall Urged in FDA Petition Filed by Public Citizen December 8, 2017 Benicar Settlement to Result in $300M Payment By Drug Maker for Gastrointestinal Injuries August 1, 2017 Benicar Lawsuits Over Diarrhea, Gastrointestinal Problems Filed By Nearly 2,000 July 17, 2017 1 Comments Jamaine May 22, 2014 I was prescribed Benicar by my physician and I stay having these symptoms shortly after taking the drug. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermNameThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES 12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (Posted: yesterday) A dozen hair dye lawsuits over bladder cancer risks have been consolidated under one California state judge for coordinated pretrial proceedings. MORE ABOUT: HAIR DYE LAWSUITJudge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025) BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: 2 days ago) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025) Whippet Lawsuit Alleges Nitrous Oxide Addiction Resulted in Paralysis, Nerve Damage (Posted: 5 days ago) A class action lawsuit claims nitrous oxide canisters sold under names like GreatWhip and Galaxy Gas were illegally marketed for recreational use, leading to widespread addiction, nerve damage and paralysis among young users. MORE ABOUT: NITROUS OXIDE LAWSUITGalaxy Gas Class Action Lawsuit Over Deceptive Marketing of Nitrous Oxide Amended (06/16/2025)FDA Updates List of Nitrous Oxide Inhalant Products That Pose Serious Health Risks (06/06/2025)Nitrous Oxide Addiction Lawsuit Claims Manufacturer Concealed Galaxy Gas Side Effects (05/01/2025)
Benicar Settlement to Result in $300M Payment By Drug Maker for Gastrointestinal Injuries August 1, 2017
12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (Posted: yesterday) A dozen hair dye lawsuits over bladder cancer risks have been consolidated under one California state judge for coordinated pretrial proceedings. MORE ABOUT: HAIR DYE LAWSUITJudge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)
BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: 2 days ago) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)
Whippet Lawsuit Alleges Nitrous Oxide Addiction Resulted in Paralysis, Nerve Damage (Posted: 5 days ago) A class action lawsuit claims nitrous oxide canisters sold under names like GreatWhip and Galaxy Gas were illegally marketed for recreational use, leading to widespread addiction, nerve damage and paralysis among young users. MORE ABOUT: NITROUS OXIDE LAWSUITGalaxy Gas Class Action Lawsuit Over Deceptive Marketing of Nitrous Oxide Amended (06/16/2025)FDA Updates List of Nitrous Oxide Inhalant Products That Pose Serious Health Risks (06/06/2025)Nitrous Oxide Addiction Lawsuit Claims Manufacturer Concealed Galaxy Gas Side Effects (05/01/2025)